Volume-regulated anion channel (VRAC)

The **Volume-regulated anion channel** (VRAC) is a membrane protein complex formed primarily by heteromeric assemblies of leucine-rich repeat-containing protein 8 (LRRC8) family subunits (A–E), with LRRC8A (SWELL1) as the essential core component[1][2][6][8][9]. VRACs are ubiquitously expressed in vertebrate cells and are activated by cell swelling under hypotonic or low ionic strength conditions[3][7][5]. Upon activation, VRACs mediate the efflux of chloride ions and a variety of organic osmolytes (such as taurine and glutamate), restoring cell volume in a process known as the *regulatory volume decrease* (RVD)[3][5][4]. The specific functional properties of VRAC—such as ion selectivity and substrate permeability—depend on the precise subunit composition of the channel, with certain combinations (e.g., LRRC8A/D) permitting passage of larger molecules, including chemotherapy drugs like cisplatin[6][10]. Beyond cell volume regulation, VRACs are implicated in cell proliferation, apoptosis, immune function, and neuronal signaling[5][3]. Pharmacological inhibitors such as DCPIB and DIDS can block VRAC activity, but highly specific modulators are not yet clinically available[4][6]. Disruption or dysregulation of VRAC function has potential pathogenic relevance in cancer, stroke, immunodeficiency, and other diseases[3][5].

Other names

Volume-sensitive outwardly rectifying anion channelVolume-sensitive organic osmolyte/anion channelLRRC8 channelSWELL1 channel

Blockade or inhibition of anion efflux and volume regulation (DCPIB, DIDS), Facilitation of drug entry into cells (e.g., cisplatin, blasticidin S, via LRRC8D-containing VRAC)